preview

Summary: Current Treatment Approaches

Decent Essays
Open Document

Current Treatment Approaches There are several approaches to integrate substance abuse treatment into the criminal justice process such as treatment while under drug court supervision, while in prison followed by community-based treatment, or as a condition of parole or probation. The Florida State prison system offers four types of treatment during incarceration, intensive outpatient, residential therapeutic community, transitional re-entry programs, work release center outpatient and after-care services, and outpatient, non-secure and secure community corrections SUD treatment programs (FDLE, 2013). However, due to lack of availability and limited financial support program efficacy remains highly questionable (FDLE, 2013). In general, currently …show more content…

Harm reduction is a non-judgmental and practical approach to prevent HIV/HCV seroconversions, overdose, death, and decrease adverse effects on self and community (NPNU Initiative, 2007). Successful prison harm reduction programs frequently include pharmacotherapy, which plays a key role in helping with withdrawal symptoms and relapse prevention. Numerous studies on the effectiveness of opioid maintenance treatments (OMT) such as methadone, buprenorphine, levo-alpha acetyl methadol (LAAM) and buprenorphine-naloxone have proven that the benefits of OMT pre-release are similar to community treatment (Hedrich et al. 2012). A substantial reduction in prison drug use was shown on studies reporting illicit opioid use, and the studies that compared OMT to no OMT during incarceration shown impressively large differences (Hedrich et al. 2012). The studies which reported drug injection activity found a considerable reduction in injecting and syringe sharing (Hedrich et al, 2012). An Australian OMT study measuring HIV/HCV seroconversion resulted in no HIV seroconversions during incarceration, with both the control group and treatment groups having a high HCV risk dominance with equivalent seroconversions in both groups. Dolan et al. (1998, 1996) determined a reduction in risk behaviors for continuous high dose (>60mg.) therapy versus limited low dose therapy. A 2001 Canadian study measuring inmate transgressions reported drug violations in prison shrank in the OMT group, while it amplified in the control group (Hedrich et al.

Get Access